Skip to main content
. 2022 Dec 15;47:29–35. doi: 10.1016/j.euros.2022.11.005

Supplementary Figure 2.

Supplementary Figure 2

Overall survival from the start of treatment for patients undergoing pelvic treatment as primary treatment or as part of the treatment of a recurrence.